397
Views
2
CrossRef citations to date
0
Altmetric
Short Communications

Use of Crotalidae equine immune F(ab’)2 antivenom for treatment of an Agkistrodon envenomation

, , , &
Pages 1023-1026 | Received 21 Dec 2020, Accepted 15 Feb 2021, Published online: 11 Mar 2021

References

  • Gummin DD, Mowry JB, Spyker DA, et al. 2018 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila). 2019;57(12):1220–1413.
  • Ruha A-M, Kleinschmidt KC, Greene S, et al. The epidemiology, clinical course, and management of snakebites in the North American Snakebite Registry. J Med Toxicol. 2017;13(4):309–320.
  • Kopec KT, Yen M, Bitner M, et al. Marked hypofibrinogenemia and gastrointestinal bleeding after copperhead (Agkistrodon contortrix) envenomation. Wilderness Environ Med. 2015;26(4):488–490.
  • Domanski K, Kleinschmidt KC, Greene S, et al. Cottonmouth snake bites reported to the ToxIC North American snakebite registry 2013–2017. Clin Toxicol (Phila). 2020;58(3):178–182.
  • Lavonas EJ, Ruha A-M, Banner W, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011;11:2.
  • Corbett B, Clark RF. North American snake envenomation. Emerg Med Clin North Am. 2017;35(2):339–354.
  • Gutiérrez JM, Calvete JJ, Habib AG, et al. Snakebite envenoming. Nat Rev Dis Primers. 2017;3:17063.
  • Roth B, Sharma K, Onisko N, et al. Prospective evaluation of pain, swelling, and disability from copperhead envenomation. Clin Toxicol (Phila). 2016;54(3):271–276.
  • Gerardo CJ, Quackenbush E, Lewis B, et al. The efficacy of crotalidae polyvalent immune fab (ovine) antivenom versus placebo plus optional rescue therapy on recovery from copperhead snake envenomation: a randomized, double-blind, placebo-controlled, clinical trial. Ann Emerg Med. 2017;70(2):233–244.
  • Anderson VE, Gerardo CJ, Rapp-Olsson M, et al. Early administration of Fab antivenom resulted in faster limb recovery in copperhead snake envenomation patients. Clin Toxicol (Phila). 2019;57(1):25–30.
  • Freiermuth CE, Lavonas EJ, Anderson VE, et al. Antivenom treatment is associated with fewer patients using opioids after copperhead envenomation. West J Emerg Med. 2019;20(3):497–505.
  • Sánchez EE, Galán JA, Perez JC, et al. The efficacy of two antivenoms against the venom of North American snakes. Toxicon. 2003;41(3):357–365.
  • Sánchez EE, Ramírez MS, Galán JA, et al. Cross reactivity of three antivenoms against North American snake venoms. Toxicon. 2003;41(3):315–320.
  • Bush SP, Ruha A-M, Seifert SA, et al. Comparison of F(ab’)2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial. Clin Toxicol. 2015;53(1):37–45.
  • Gerardo CJ, Vissoci JRN, Brown MWJ, et al. Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab')2 versus Fab antivenom trial . Clin Toxicol (Phila). 2017;55(2):109–114.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.